ICD-10-CM Billable Code

G21.9

Secondary parkinsonism, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Secondary Parkinsonism is a condition that mimics Parkinson's disease but results from other causes, such as certain medications or underlying medical issues. Unlike primary Parkinson's disease, which develops gradually without a clear external factor, secondary Parkinsonism is directly linked to identifiable causes. This condition manifests with symptoms similar to Parkinson's disease and affects movement and coordination, but it often has a different course and prognosis depending on its cause.

Causes & Symptoms

Clinical Causes: Use of certain medications, especially antipsychotics and anti-nausea drugs Exposure to neurotoxins or environmental toxins Brain injuries or strokes affecting motor control areas Infections that impact the nervous system Metabolic disorders such as Wilson’s disease

Key Symptoms: Bradykinesia, or slowness of movement Muscle rigidity or stiffness Resting tremor, often starting in one limb Postural instability and balance problems Shuffling gait and difficulty with coordination Reduced facial expression, sometimes called 'masked face' Speech difficulties, such as softer or slurred speech Difficulty swallowing in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing secondary Parkinsonism involves a comprehensive review of medical history, including medication use and exposure to toxins. A physical and neurological examination assesses movement and muscle tone. Additional tests, such as brain imaging (MRI or CT scans), may be performed to rule out other neurological conditions and identify potential causes. Blood tests can also help evaluate metabolic or infectious causes. Recognizing the cause is essential for guiding treatment and management.

Treatment Protocols: Treatment strategies focus on addressing the underlying cause and managing symptoms. Discontinuing or adjusting causative medications may lead to symptom improvement. In some cases, medications used for Parkinson's disease, like levodopa or dopamine agonists, can be beneficial, although their effectiveness varies. Physical and occupational therapy can help improve mobility and daily function. Managing associated issues, such as depression or cognitive changes, is also important. The overall approach aims to enhance quality of life and mobility.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G21.9 a billable ICD-10 code?
Yes, G21.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G21.9?
Clinical documentation must specify the nature of Secondary parkinsonism, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes